SB
Sally E. Blount (Director) filed 1 Form 4 report in the past 24 months (0 purchases, 1 sale), most often in Abbott Laboratories (ABT). The largest single filing was $337K of ABT (2,600 sh × $129.66, as filed), executed Apr 30 2025. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$337K
shares × price, as filed
Last traded
Apr 30 2025
Filed May 2 2025
Median ADV $1.4B across their filed names
Open performance→Volume by month
Buys $0
Sells $337K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
ABTRecent filings
ABTSALE
Abbott Laboratories
View filing →
$337K2,600 sh × $129.66
Exec Apr 30 2025
Filed May 2 2025 · 5:30 PM ET